Search results for: stress

President’s Perspective: New ACR Lupus Initiative Program Helps Identify and Eliminate Bias in Rheumatology Practices

Audrey B. Uknis, MD | May 1, 2013

CME series “Conscious and Unconscious Biases in Healthcare: Focus on Lupus” has curriculum and tools to reduce healthcare disparities

Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease

Simon M. Helfgott, MD | May 1, 2013

Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders

ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

Staff | May 1, 2013

Toxicity and appropriate targeting are challenges for small molecule researchers

President’s Perspective: ACR Calls on Members to Advance Rheumatology

Audrey B. Uknis, MD | April 1, 2013

Members’ support and participation is needed to strengthen the ACR’s lobbying efforts with Congress

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

ACR/ARHP Annual Meeting 2012: Tips to Diagnose and Treat Catastrophic Antiphospholipid Syndrome (CAPS)

Thomas R. Collins | April 1, 2013

CAPS is a rare, complex disease which involves sudden clotting on multiple fronts

ACR/ARHP Annual Meeting 2012: Genes Not the Only Factor in Susceptibility to Rheumatoid Arthritis

Susan Bernstein | March 1, 2013

Epigenetics, innate immunity, and environmental stresses such as smoking could have more influence than scientists once believed

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD | March 1, 2013

Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

Research into Methotrexate Could Lead to Improved Treatments for Rheumatoid Arthritis

Staff | March 1, 2013

With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints

ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost

Thomas R. Collins | March 1, 2013

The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies